Neurosurgical Review

, Volume 26, Issue 4, pp 233–246 | Cite as

Advances in neuroimaging: management of partial epileptic syndromes

Review
First Online:
Received:
Accepted:

Abstract

Structural and functional neuroimaging studies are essential in the evaluation of individuals with partial epilepsy syndromes. Magnetic resonance imaging (MRI) is important to delineate structural abnormalities underlying seizure disorders, commonly including hippocampal sclerosis or cortical dysplasias. Identification of a structural lesion is often a reliable indicator of the site of seizure onset. Magnetic resonance spectroscopy (MRS) allows us to investigate cerebral metabolites and some neurotransmitters. Reduction in various metabolite concentrations has proven to be prognostically valuable when no structural abnormality is identified. Positron emission tomography (PET) using deoxyglucose demonstrates areas of reduced glucose metabolism, which are the hallmark of epileptogenic zones and usually extend beyond the underlying anatomical region. It is useful in temporal lobe epilepsy for lateralization; however, results in extratemporal lobe epilepsy have been less favorable. More promising is the use of benzodiazepine receptor ligands, which are reduced in the epileptogenic zone in a more restricted distribution. This appears to be helpful in the localization of extratemporal seizure foci. Peri-ictal single photon emission computed tomography measures increased blood flow during the ictal event and is beneficial in patients with normal MRI studies to determine lateralization and localization of the ictal onset zone. All imaging modalities should be correlated with clinical and neurophysiological data.

Keywords

Magnetic resonance spectroscopy Partial epilepsy Positron emission tomography Review Single photon emission computed tomography (SPECT) Peri-ictal SPECT Substraction ictal SPECT coregistered on magnetic resonance imaging 
This is a preview of subscription content, log in to check access.

References

  1. 1.
    Aronica E, Leenstra S, van Veelen CW, van Rijen PC, Hulsebos TJ, Tersmette AC, Yankaya B, Troost D (2001) Glioneuronal tumors and medically intractable epilepsy: a clinical study with long-term follow-up of seizure outcome after surgery. Epilepsy Res 43:179–191Google Scholar
  2. 2.
    Barkovich AJ, Kuzniecky RI, Dobyns WB (2001) Radiologic classification of malformations of cortical development. Curr Opin Neurol 14:145–149CrossRefPubMedGoogle Scholar
  3. 3.
    Berkovic SF (2000) SPECT: neurobiology of periictal blood flow alterations. Adv Neurol 83:33–39PubMedGoogle Scholar
  4. 4.
    Berkovic SF, Andermann F, Olivier A, Ethier R, Melanson D, Robitaille Y, Kuzniecky R, Peters T, Feindel W (1991) Hippocampal sclerosis in temporal lobe epilepsy demonstrated by magnetic resonance imaging. Ann Neurol 29:175–182PubMedGoogle Scholar
  5. 5.
    Bernardi S, Trimble MR, Frackowiak RS, Wise RJ, Jones T (1983) An interictal study of partial epilepsy using positron emission tomography and the oxygen-15 inhalation technique. J Neurol Neurosurg Psychiatry 46:473–477PubMedGoogle Scholar
  6. 6.
    Brinkmann BH, O'Brien TJ, Webster DB, Mullan BP, Robins PD, Robb RA (2000) Voxel significance mapping using local image variances in subtraction ictal SPET. Nucl Med Commun 21:545–551CrossRefPubMedGoogle Scholar
  7. 7.
    Britton JW, Cascino GD, Sharbrough FW, Kelly PJ (1994) Low-grade glial neoplasms and intractable partial epilepsy: efficacy of surgical treatment. Epilepsia 35:1130–1135PubMedGoogle Scholar
  8. 8.
    Bronen RA, Cheung G, Charles JT, Kim JH, Spencer DD, Spencer SS, Sze G, McCarthy G (1991) Imaging findings in hippocampal sclerosis: correlation with pathology. AJNR Am J Neuroradiol 12:933–940PubMedGoogle Scholar
  9. 9.
    Carpio A, Escobar A, Hauser WA (1998) Cysticercosis and epilepsy: a critical review. Epilepsia 39:1025–1040PubMedGoogle Scholar
  10. 10.
    Carreno M, Luders HO (2000) General principles of presurgical evaluation. In: Luders HO, Comair Y (eds) Epilepsy surgery, 2nd edn. Lippincott, Philadelphia, pp 185–199Google Scholar
  11. 11.
    Cascino GD (1990) Epilepsy and brain tumors: implications for treatment. Epilepsia 31 [Suppl 3]:S37–S44Google Scholar
  12. 12.
    Cascino GD (1994) Commentary: how has neuroimaging improved patient care? Epilepsia 35 [Suppl 6]:S103–S107Google Scholar
  13. 13.
    Cascino GD (1995) Structural neuroimaging in partial epilepsy. Magnetic resonance imaging. Neurosurg Clin N Am 6:455–464PubMedGoogle Scholar
  14. 14.
    Cascino GD (2001) Advances in neuroimaging: surgical localization. Epilepsia 42:3–12CrossRefGoogle Scholar
  15. 15.
    Cascino GD, Jack CR Jr, Parisi JE, Sharbrough FW, Hirschorn KA, Meyer FB, Marsh WR, O'Brien PC (1991) Magnetic resonance imaging-based volume studies in temporal lobe epilepsy: pathological correlations. Ann Neurol 30:31–36Google Scholar
  16. 16.
    Cascino GD, Jack CR Jr, Parisi JE, Marsh WR, Kelly PJ, Sharbrough FW, Hirschorn KA, Trenerry MR (1992) MRI in the presurgical evaluation of patients with frontal lobe epilepsy and children with temporal lobe epilepsy: pathologic correlation and prognostic importance. Epilepsy Res 11:51–59PubMedGoogle Scholar
  17. 17.
    Cascino GD, Jack CR Jr, Parisi JE, Sharbrough FW, Schreiber CP, Kelly PJ, Trenerry MR (1993) Operative strategy in patients with MRI-identified dual pathology and temporal lobe epilepsy. Epilepsy Res 14:175–182PubMedGoogle Scholar
  18. 18.
    Cascino GD, Sharbrough FW, Trenerry MR, Marsh WR, Kelly PJ, So E (1994) Extratemporal cortical resections and lesionectomies for partial epilepsy: complications of surgical treatment. Epilepsia 35:1085–1090PubMedGoogle Scholar
  19. 19.
    Cascino GD, Trenerry MR, So EL, Sharbrough FW, Shin C, Lagerlund TD, Zupanc ML, Jack CR Jr (1996) Routine EEG and temporal lobe epilepsy: relation to long-term EEG monitoring, quantitative MRI, and operative outcome. Epilepsia 37:651–656PubMedGoogle Scholar
  20. 20.
    Cendes F, Andermann F, Dubeau F, Gloor P, Evans A, Jones-Gotman M, Olivier A, Andermann E, Robitaille Y, Lopes-Cendes I et al (1993) Early childhood prolonged febrile convulsions, atrophy and sclerosis of mesial structures, and temporal lobe epilepsy: an MRI volumetric study. Neurology 43:1083–1087PubMedGoogle Scholar
  21. 21.
    Cendes F, Andermann F, Gloor P, Lopes-Cendes I, Andermann E, Melanson D, Jones-Gotman M, Robitaille Y, Evans A, Peters T (1993) Atrophy of mesial structures in patients with temporal lobe epilepsy: cause or consequence of repeated seizures? Ann Neurol 34:795–801Google Scholar
  22. 22.
    Cendes F, Andermann F, Dubeau F, Matthews PM, Arnold DL (1997) Normalization of neuronal metabolic dysfunction after surgery for temporal lobe epilepsy. Evidence from proton MR spectroscopic imaging. Neurology 49:1525–1533PubMedGoogle Scholar
  23. 23.
    Cendes F, Caramanos Z, Andermann F, Dubeau F, Arnold DL (1997) Proton magnetic resonance spectroscopic imaging and magnetic resonance imaging volumetry in the lateralization of temporal lobe epilepsy: a series of 100 patients. Ann Neurol 42:737–746PubMedGoogle Scholar
  24. 24.
    Connelly A, Jackson GD, Duncan JS, King MD, Gadian DG (1994) Magnetic resonance spectroscopy in temporal lobe epilepsy. Neurology 44:1411–1417PubMedGoogle Scholar
  25. 25.
    Constantinidis I (2000) MRS methodology. Adv Neurol 83:235–246PubMedGoogle Scholar
  26. 26.
    Daumas-Duport C (1993) Dysembryoplastic neuroepithelial tumours. Brain Pathol 3:283–295PubMedGoogle Scholar
  27. 27.
    Devous MD Sr, Thisted RA, Morgan GF, Leroy RF, Rowe CC (1998) SPECT brain imaging in epilepsy: a meta-analysis. J Nucl Med 39:285–293PubMedGoogle Scholar
  28. 28.
    Duncan JS (1997) Imaging and epilepsy. Brain 120:339–377CrossRefPubMedGoogle Scholar
  29. 29.
    Duncan JS, Koepp MJ (2000) PET: central benzodiazepine neuroreceptor mapping in localization-related epilepsies. Adv Neurol 83:131–136PubMedGoogle Scholar
  30. 30.
    Engel J Jr (2000) Overview of functional neuroimaging in epilepsy. Adv Neurol 83:1–9PubMedGoogle Scholar
  31. 31.
    Engel J Jr (2001) Finally, a randomized, controlled trial of epilepsy surgery. N Engl J Med 345:365–367CrossRefPubMedGoogle Scholar
  32. 32.
    Engel J Jr, Brown WJ, Kuhl DE, Phelps ME, Mazziotta JC, Crandall PH (1982) Pathological findings underlying focal temporal lobe hypometabolism in partial epilepsy. Ann Neurol 12:518–528Google Scholar
  33. 33.
    Engel J Jr, Kuhl DE, Phelps ME, Crandall PH (1982) Comparative localization of epileptic foci in partial epilepsy by PCT and EEG. Ann Neurol 12:529–537Google Scholar
  34. 34.
    Engel J Jr, Kuhl DE, Phelps ME, Mazziotta JC (1982) Interictal cerebral glucose metabolism in partial epilepsy and its relation to EEG changes. Ann Neurol 12:510–517PubMedGoogle Scholar
  35. 35.
    Forsyth PA, Shaw EG, Scheithauer BW, O'Fallon JR, Layton DD Jr, Katzmann JA (1993) Supratentorial pilocytic astrocytomas. A clinicopathologic, prognostic, and flow cytometric study of 51 patients. Cancer 72:1335–1342PubMedGoogle Scholar
  36. 36.
    Gadian DG, Connelly A, Duncan JS, Cross JH, Kirkham FJ, Johnson CL, Vargha-Khadem F, Nevile BG, Jackson GD (1994) 1H magnetic resonance spectroscopy in the investigation of intractable epilepsy. Acta Neurol Scand Suppl 152:116–121PubMedGoogle Scholar
  37. 37.
    Gaillard WD, Fazilat S, White S, Malow B, Sato S, Reeves P, Herscovitch P, Theodore WH (1995) Interictal metabolism and blood flow are uncoupled in temporal lobe cortex of patients with complex partial epilepsy. Neurology 45:1841–1847PubMedGoogle Scholar
  38. 38.
    Garcia PA, Laxer KD, van der Grond J, Hugg JW, Matson GB, Weiner MW (1995) Proton magnetic resonance spectroscopic imaging in patients with frontal lobe epilepsy. Ann Neurol 37:279–281PubMedGoogle Scholar
  39. 39.
    Gastaut H, Gastaut JL (1976) Computerized transverse axial tomography in epilepsy. Epilepsia 17:325–336PubMedGoogle Scholar
  40. 40.
    Grafton ST (2000) PET: activation of cerebral blood flow and glucose metabolism. Adv Neurol 83:87–103PubMedGoogle Scholar
  41. 41.
    Hajek M, Siegel AM, Haldemann R, von Schulthess GK, Wieser HG (1991) Value of HMPAO-SPECT in the selective temporal lobe surgery for epilepsy. J Epilepsy 4:43–51Google Scholar
  42. 42.
    Hajek M, Wieser HG, Khan N, Antonini A, Schrott PR, Maguire P, Beer HF, Leenders KL (1994) Preoperative and postoperative glucose consumption in mesiobasal and lateral temporal lobe epilepsy. Neurology 44:2125–2132PubMedGoogle Scholar
  43. 43.
    Hammers A, Koepp MJ, Richardson MP, Labbe C, Brooks DJ, Cunningham VJ, Duncan JS (2001) Central benzodiazepine receptors in malformations of cortical development: a quantitative study. Brain 124:1555-1565CrossRefPubMedGoogle Scholar
  44. 44.
    Hauser WA, Hesdorffer DC (1990) Epilepsy: frequency, causes and consequences. Demos, New YorkGoogle Scholar
  45. 45.
    Henry TR, Babb TL, Engel J Jr, Mazziotta JC, Phelps ME, Crandall PH (1994) Hippocampal neuronal loss and regional hypometabolism in temporal lobe epilepsy. Ann Neurol 36:925–927Google Scholar
  46. 46.
    Ho SS, Berkovic SF, Berlangieri SU, Newton MR, Egan GF, Tochon-Danguy HJ, McKay WJ (1995) Comparison of ictal SPECT and interictal PET in the presurgical evaluation of temporal lobe epilepsy. Ann Neurol 37:738–745Google Scholar
  47. 47.
    Hugg JW, Laxer KD, Mattson GB (1992) 1H MR spectroscopic imaging detects neuron loss more sensitively than MRI in focal epilepsy. Proc Soc Magn Reson Med:1913Google Scholar
  48. 48.
    Hugg JW, Kuzniecky RI, Gilliam FG, Morawetz RB, Fraught RE, Hetherington HP (1996) Normalization of contralateral metabolic function following temporal lobectomy demonstrated by 1H magnetic resonance spectroscopic imaging. Ann Neurol 40:236–239Google Scholar
  49. 49.
    Ildan F, Tuna M, Gocer IA, Erman T, Cetinalp E (2001) Intracerebral ganglioglioma: clinical and radiological study of eleven surgically treated cases with follow-up. Neurosurg Rev 24:114–118PubMedGoogle Scholar
  50. 50.
    Jack CR (2000) Neuroimaging of the temporal lobe. In: Luders HO, Comair Y (eds) Epilepsy surgery, 2nd edn. Lippincott, Philadelphia, pp 227–237Google Scholar
  51. 51.
    Jack CR Jr, Sharbrough FW, Twomey CK, Cascino GD, Hirschorn KA, Marsh WR, Zinsmeister AR, Scheithauer B (1990) Temporal lobe seizures: lateralization with MR volume measurements of the hippocampal formation. Radiology 175:423–429PubMedGoogle Scholar
  52. 52.
    Jack CR Jr, Sharbrough FW, Cascino GD, Hirschorn KA, O'Brien PC, Marsh WR (1992) Magnetic resonance image-based hippocampal volumetry: correlation with outcome after temporal lobectomy. Ann Neurol 31:138–146PubMedGoogle Scholar
  53. 53.
    Jack CR Jr, Mullan BP, Sharbrough FW, Cascino GD, Hauser MF, Krecke KN, Luetmer PH, Trenerry MR, O'Brien PC, Parisi JE (1994) Intractable nonlesional epilepsy of temporal lobe origin: lateralization by interictal SPECT versus MRI. Neurology 44:829–836PubMedGoogle Scholar
  54. 54.
    Jack CR Jr, Trenerry MR, Cascino GD, Sharbrough FW, So EL, O'Brien PC (1995) Bilaterally symmetric hippocampi and surgical outcome. Neurology 45:1353–1358PubMedGoogle Scholar
  55. 55.
    Jack CR Jr, Rydberg CH, Krecke KN, Trenerry MR, Parisi JE, Rydberg JN, Cascino GD, Riederer SJ (1996) Mesial temporal sclerosis: diagnosis with fluid-attenuated inversion-recovery versus spin-echo MR imaging. Radiology 199:367–373PubMedGoogle Scholar
  56. 56.
    Jackson GD, Berkovic SF, Duncan JS, Connelly A (1993) Optimizing the diagnosis of hippocampal sclerosis using MR imaging. AJNR Am J Neuroradiol 14:753–762PubMedGoogle Scholar
  57. 57.
    Johnson JH Jr, Hariharan S, Berman J, Sutton LN, Rorke LB, Molloy P, Phillips PC (1997) Clinical outcome of pediatric gangliogliomas: ninety-nine cases over 20 years. Pediatr Neurosurg 27:203–207PubMedGoogle Scholar
  58. 58.
    Kleihues P, Davis RL, Ohgaki H, Burger PC, Westphal MM, Cavanee WK (2000) Diffuse astrocytoma. In: Kleihues P, Cavanee WK (eds) Pathology and genetics: tumours of the nervous system, vol 1. International Agency for Research on Cancer, LyonGoogle Scholar
  59. 59.
    Koepp MJ, Richardson MP, Brooks DJ, Poline JB, Van Paesschen W, Friston KJ, Duncan JS (1996) Cerebral benzodiazepine receptors in hippocampal sclerosis. An objective in vivo analysis. Brain 119:1677–1687PubMedGoogle Scholar
  60. 60.
    Kuzniecky RI (1995) Neuronal migration disorders. Neurology 45:2120Google Scholar
  61. 61.
    Kuzniecky RI, Barkovich AJ (2001) Malformations of cortical development and epilepsy. Brain Dev 23:2–11CrossRefPubMedGoogle Scholar
  62. 62.
    Kuzniecky R, Andermann F, Tampieri D, Melanson D, Olivier A, Leppik I (1989) Bilateral central macrogyria: epilepsy, pseudobulbar palsy, and mental retardation—a recognizable neuronal migration disorder. Ann Neurol 25:547–554PubMedGoogle Scholar
  63. 63.
    Kuzniecky R, Garcia JH, Faught E, Morawetz RB (1991) Cortical dysplasia in temporal lobe epilepsy: magnetic resonance imaging correlations. Ann Neurol 29:293–298PubMedGoogle Scholar
  64. 64.
    Kuzniecky R, Murro A, King D, Morawetz R, Smith J, Powers R, Yaghmai F, Faught E, Gallagher B, Snead OC (1993) Magnetic resonance imaging in childhood intractable partial epilepsies: pathologic correlations. Neurology 43:681–687PubMedGoogle Scholar
  65. 65.
    Lamusuo S, Pitkanen A, Jutila L, Ylinen A, Partanen K, Kalviainen R, Ruottinen HM, Oikonen V, Nagren K, Lehikoinen P, Vapalahti M, Vainio P, Rinne JO (2000) [11 C]Flumazenil binding in the medial temporal lobe in patients with temporal lobe epilepsy: correlation with hippocampal MR volumetry, T2 relaxometry, and neuropathology. Neurology 54:2252–2260PubMedGoogle Scholar
  66. 66.
    Lancman ME, Morris HH III, Raja S, Sullivan MJ, Saha G, Go R (1997) Usefulness of ictal and interictal 99mTc ethyl cysteinate dimer single photon emission computed tomography in patients with refractory partial epilepsy. Epilepsia 38:466–471PubMedGoogle Scholar
  67. 67.
    Laxer KD (2000) Phosphorus MRS: pH, ATP, PCr. Adv Neurol 83:273–277PubMedGoogle Scholar
  68. 68.
    Lee YY, Van Tassel P, Bruner JM, Moser RP, Share JC (1989) Juvenile pilocytic astrocytomas: CT and MR characteristics. AJR Am J Roentgenol 152:1263–1270PubMedGoogle Scholar
  69. 69.
    Lewis PJ, Siegel A, Siegel AM, Studholme C, Sojkova J, Roberts DW, Thadani VM, Gilbert KL, Darcey TM, Williamson PD (2000) Does performing image registration and subtraction in ictal brain SPECT help localize neocortical seizures? J Nucl Med 41:1619–1626PubMedGoogle Scholar
  70. 70.
    Li LM, Cendes F, Bastos AC, Andermann F, Dubeau F, Arnold DL (1998) Neuronal metabolic dysfunction in patients with cortical developmental malformations: a proton magnetic resonance spectroscopic imaging study. Neurology 50:755–759PubMedGoogle Scholar
  71. 71.
    Martin RC, Sawrie SM, Knowlton RC, Bilir E, Gilliam FG, Faught E, Morawetz RB, Kuzniecky R (2001) Bilateral hippocampal atrophy: consequences to verbal memory following temporal lobectomy. Neurology 57:597–604PubMedGoogle Scholar
  72. 72.
    Maton BM, Kuzniecky RI (2000) Proton MRS: N-acetyl aspartate, creatine, and choline. Adv Neurol 83:253–259PubMedGoogle Scholar
  73. 73.
    Mattson RH (1992) Drug treatment of partial epilepsy. Adv Neurol 57:643–650PubMedGoogle Scholar
  74. 74.
    Mottolese C, Hermier M, Stan H, Jouvet A, Saint-Pierre G, Froment JC, Bret P, Lapras C (2001) Central nervous system cavernomas in the pediatric age group. Neurosurg Rev 24:55–73PubMedGoogle Scholar
  75. 75.
    Mullan BP, O'Connor MK, Hung JC (1995) Single photon emission computed tomography. Neuroimaging Clin N Am 5:647–673PubMedGoogle Scholar
  76. 76.
    Muzik O, da Silva EA, Juhasz C, Chugani DC, Shah J, Nagy F, Canady A, von Stockhausen HM, Herholz K, Gates J, Frost M, Ritter F, Watson C, Chugani HT (2000) Intracranial EEG versus flumazenil and glucose PET in children with extratemporal lobe epilepsy. Neurology 54:171–179PubMedGoogle Scholar
  77. 77.
    Nishio S, Morioka T, Hisada K, Fukui M (2000) Temporal lobe epilepsy: a clinicopathological study with special reference to temporal neocortical changes. Neurosurg Rev 23:84–89CrossRefPubMedGoogle Scholar
  78. 78.
    Nishio S, Morioka T, Mihara F, Gondo K, Fukui M (2001) Cerebral ganglioglioma with epilepsy: neuroimaging features and treatment. Neurosurg Rev 24:14–19PubMedGoogle Scholar
  79. 79.
    O'Brien TJ (2000) SPECT: methodology. Adv Neurol 83:11–32PubMedGoogle Scholar
  80. 80.
    O'Brien TJ, Newton MR, Cook MJ, Berlangieri SU, Kilpatrick C, Morris K, Berkovic SF (1997) Hippocampal atrophy is not a major determinant of regional hypometabolism in temporal lobe epilepsy. Epilepsia 38:74–80PubMedGoogle Scholar
  81. 81.
    O'Brien TJ, O'Connor MK, Mullan BP, Brinkmann BH, Hanson D, Jack CR, So EL (1998) Subtraction ictal SPET co-registered to MRI in partial epilepsy: description and technical validation of the method with phantom and patient studies. Nucl Med Commun 19:31–45PubMedGoogle Scholar
  82. 82.
    O'Brien TJ, So EL, Mullan BP, Hauser MF, Brinkmann BH, Bohnen NI, Hanson D, Cascino GD, Jack CR Jr, Sharbrough FW (1998) Subtraction ictal SPECT co-registered to MRI improves clinical usefulness of SPECT in localizing the surgical seizure focus. Neurology 50:445–454PubMedGoogle Scholar
  83. 83.
    O'Brien TJ, Brinkmann BH, Mullan BP, So EL, Hauser MF, O'Connor MK, Hung J, Jack CR (1999) Comparative study of 99mTc-ECD and 99mTc-HMPAO for peri-ictal SPECT: qualitative and quantitative analysis. J Neurol Neurosurg Psychiatry 66:331–339PubMedGoogle Scholar
  84. 84.
    O'Brien TJ, So EL, Meyer FB, Parisi JE, Jack CR (1999) Progressive hippocampal atrophy in chronic intractable temporal lobe epilepsy. Ann Neurol 45:526–529CrossRefPubMedGoogle Scholar
  85. 85.
    O'Brien TJ, So EL, Mullan BP, Hauser MF, Brinkmann BH, Jack CR Jr, Cascino GD, Meyer FB, Sharbrough FW (1999) Substraction SPECT co-registered to MRI improves postictal SPECT localization of seizure foci. Neurology 52:137–146PubMedGoogle Scholar
  86. 86.
    Oldendorf WH (1984) The use and promise of nuclear magnetic resonance imaging in epilepsy. Epilepsia 25 [Suppl 2]:S105–S117Google Scholar
  87. 87.
    Palmini A, Andermann F, Olivier A, Tampieri D, Robitaille Y (1991) Focal neuronal migration disorders and intractable partial epilepsy: results of surgical treatment. Ann Neurol 30:750–757Google Scholar
  88. 88.
    Privitera MD, Yeh HS, Blisard K, Sanchez N (2000) Detection of epileptogenic focal cortical dysplasia by depth, not subdural electrodes. Neurosurg Rev 23:49–51CrossRefPubMedGoogle Scholar
  89. 89.
    Radhakrishnan K, So EL, Silbert PL, Jack CR Jr, Cascino GD, Sharbrough FW, O'Brien PC (1998) Predictors of outcome of anterior temporal lobectomy for intractable epilepsy: a multivariate study. Neurology 51:465–471PubMedGoogle Scholar
  90. 90.
    Raymond AA, Halpin SF, Alsanjari N, Cook MJ, Kitchen ND, Fish DR, Stevens JM, Harding BN, Scaravilli F, Kendall B et al (1994) Dysembryoplastic neuroepithelial tumor. Features in 16 patients. Brain 117:461–475PubMedGoogle Scholar
  91. 91.
    Raymond AA, Fish DR, Sisodiya SM, Alsanjari N, Stevens JM, Shorvon SD (1995) Abnormalities of gyration, heterotopias, tuberous sclerosis, focal cortical dysplasia, microdysgenesis, dysembryoplastic neuroepithelial tumour and dysgenesis of the archicortex in epilepsy. Clinical, EEG and neuroimaging features in 100 adult patients. Brain 118:629–660PubMedGoogle Scholar
  92. 92.
    Richardson MP, Koepp MJ, Brooks DJ, Duncan JS (1998) 11C-flumazenil PET in neocortical epilepsy. Neurology 51:485–492PubMedGoogle Scholar
  93. 93.
    Rowe CC, Berkovic SF, Austin MC, McKay WJ, Bladin PF (1991) Patterns of postictal cerebral blood flow in temporal lobe epilepsy: qualitative and quantitative analysis. Neurology 41:1096–1103PubMedGoogle Scholar
  94. 94.
    Ryvlin P, Bouvard S, Le Bars D, De Lamerie G, Gregoire MC, Kahane P, Froment JC, Mauguiere F (1998) Clinical utility of flumazenil-PET versus [18F]fluorodeoxyglucose-PET and MRI in refractory partial epilepsy. A prospective study in 100 patients. Brain 121:2067–2081CrossRefPubMedGoogle Scholar
  95. 95.
    Sackellares JC, Siegel GJ, Abou-Khalil BW, Hood TW, Gilman S, McKeever PE, Hichwa RD, Hutchins GD (1990) Differences between lateral and mesial temporal metabolism interictally in epilepsy of mesial temporal origin. Neurology 40:1420–1426PubMedGoogle Scholar
  96. 96.
    Sano K (2001) Intracranial dysembryogenetic tumors: pathogenesis and their order of malignancy. Neurosurg Rev 24:162–167PubMedGoogle Scholar
  97. 97.
    Siegel AM, Roberts DW, Harbaugh RE, Williamson PD (2000) Pure lesionectomy versus tailored epilepsy surgery in treatment of cavernous malformations presenting with epilepsy. Neurosurg Rev 23:80–83CrossRefPubMedGoogle Scholar
  98. 98.
    Sisodiya SM, Free SL, Stevens JM, Fish DR, Shorvon SD (1995) Widespread cerebral structural changes in patients with cortical dysgenesis and epilepsy. Brain 118:1039–1050PubMedGoogle Scholar
  99. 99.
    So EL (2000) Integration of EEG, MRI, and SPECT in localizing the seizure focus for epilepsy surgery. Epilepsia 41 [Suppl 3]:S48–S54Google Scholar
  100. 100.
    Spencer SS (1994) The relative contributions of MRI, SPECT, and PET imaging in epilepsy. Epilepsia 35 [Suppl 6]:S72–S89Google Scholar
  101. 101.
    Spencer SS, Bautista RE (2000) Functional neuroimaging in localization of the ictal onset zone. Adv Neurol 83:285–296PubMedGoogle Scholar
  102. 102.
    Spencer SS, McCarthy G, Spencer DD (1993) Diagnosis of medial temporal lobe seizure onset: relative specificity and sensitivity of quantitative MRI. Neurology 43:2117–2124PubMedGoogle Scholar
  103. 103.
    Stefan H, Bauer J, Feistel H, Schulemann H, Neubauer U, Wenzel B, Wolf F, Neundorfer B, Huk WJ (1990) Regional cerebral blood flow during focal seizures of temporal and frontocentral onset. Ann Neurol 27:162–166PubMedGoogle Scholar
  104. 104.
    Stefan H, Hopp P, Platsch G, Kuwert T (2000) SPECT: ictal perfusion in localization-related epilepsies. Adv Neurol 83:41–50PubMedGoogle Scholar
  105. 105.
    Taylor DC, Falconer MA, Bruton CJ, Corsellis JA (1971) Focal dysplasia of the cerebral cortex in epilepsy. J Neurol Neurosurg Psychiatry 34:369–387PubMedGoogle Scholar
  106. 106.
    Theodore WH (2000) PET: cerebral blood flow and glucose metabolism—pathophysiology and drug effects. Adv Neurol 83:121–130PubMedGoogle Scholar
  107. 107.
    Theodore WH, Gaillard WD (2000) Positron emission tomography in neocortical epilepsies. Adv Neurol 84:435–446PubMedGoogle Scholar
  108. 108.
    Theodore WH, Fishbein D, Dubinsky R (1988) Patterns of cerebral glucose metabolism in patients with partial seizures. Neurology 38:1201–1206PubMedGoogle Scholar
  109. 109.
    Trenerry MR, Jack CR Jr, Ivnik RJ, Sharbrough FW, Cascino GD, Hirschorn KA, Marsh WR, Kelly PJ, Meyer FB (1993) MRI hippocampal volumes and memory function before and after temporal lobectomy. Neurology 43:1800–1805PubMedGoogle Scholar
  110. 110.
    Trenerry MR, Jack CR Jr, Sharbrough FW, Cascino GD, Hirschorn KA, Marsh WR, Kelly PJ, Meyer FB (1993) Quantitative MRI hippocampal volumes: association with onset and duration of epilepsy, and febrile convulsions in temporal lobectomy patients. Epilepsy Res 15:247–252PubMedGoogle Scholar
  111. 111.
    Urenjak J, Williams SR, Gadian DG, Noble M (1992) Specific expression of N-acetylaspartate in neurons, oligodendrocyte-type-2 astrocyte progenitors, and immature oligodendrocytes in vitro. J Neurochem 59:55–61PubMedGoogle Scholar
  112. 112.
    Urenjak J, Williams SR, Gadian DG, Noble M (1993) Proton nuclear magnetic resonance spectroscopy unambiguously identifies different neural cell types. J Neurosci 13:981–989PubMedGoogle Scholar
  113. 113.
    Zentner J, Hufnagel A, Wolf HK, Ostertun B, Behrens E, Campos MG, Elger CE, Wiestler OD, Schramm J (1997) Surgical treatment of neoplasms associated with medically intractable epilepsy. Neurosurgery 41:378–387PubMedGoogle Scholar

Copyright information

© Springer-Verlag 2003

Authors and Affiliations

  1. 1.Division of Epilepsy, Department of NeurologyMayo Clinic FoundationRochesterUSA

Personalised recommendations